A nationwide study on the added value of (neo)adjuvant ADT in addition to modern dose-escalated external beam radiotherapy in men with high-risk localized prostate cancer by Heesterman, B.L., Aben, K.K.H., Van Straten, C.G.J.I., Van Der Voort Van Zyp, J.R.N., Bokhorst, L.P.

Get full text

770 Improved patient selection for MRI-targeted prostate biopsy after negative random biopsy with the Rotterdam Prostate Cancer Risk Calculator by Alberts, A, Schoots, I.G, Bokhorst, L.P, Bangma, C.H, Roobol, M.J

Get full text

949 Long-term quality of life outcomes after active surveillance or curative treatment for prostate cancer by Venderbos, L.D.F, Aluwini, S.A, Roobol, M.J, Bokhorst, L.P, Oomens, E.H.G.M, Bangma, C.H, Korfage, I.J

Get full text

88 Correlation between stage shift and differences in mortality between the two study arms of the ERSPC by Roobol, M.J, Auvinen, A, Carlsson, S.V, Kwiatkowski, M, Denis, L.J, Zappa, M, Paez, A, Hugosson, J, Moss, S.M, Bokhorst, L.P

Get full text

1033 Rule-based versus probabilistic selection for active surveillance for prostate cancer by Venderbos, L.D.F, Roobol, M.J, Bangma, C.H, Van Den Bergh, R.C.N, Bokhorst, L.P, Godtman, R, Hugosson, J, Steyerberg, E.W

Get full text

115 Gleason score reclassification of men with classical Gleason score ≤6 who eventually died of prostate cancer in the ERSPC Rotterdam by Bokhorst, L.P, Kweldam, C.F, Bangma, C.H, Schröder, F.H, Van Der Kwast, T.H, Leenders, G.J.L.H, Roobol, M.J

Get full text

851 Will men with very low PSA values accept a long screening interval? by Bokhorst, L.P, Salman, J.W, Venderbos, L.D, Lous, J.J, Schröder, F.H, Bangma, C.H, Roobol, M.J

Get full text

27 Protocol based versus non-protocol based discontinuation in the Prostate cancer Research International: Active Surveillance (PRIAS) study by Bokhorst, L.P, Salman, J.W, Venderbos, L.D, Rannikko, A, Valdagni, R, Pickles, T, Kakehi, Y, Bangma, C.H, Roobol, M.J

Get full text

5 Disease-specific survival of men with screen-detected prostate cancer: Comparison of first round vs second round cancers in an European randomized screening trial by Zhu, X, Bul, M, Bokhorst, L.P, Bangma, C.H, Schröder, F.H, Roobol, M.J

Get full text

2 Verbeterde patiëntenselectie voor MRI-gerichte prostaatbiopten na negatieve systematische biopten met behulp van de Prostaatwijzer by Alberts, A.R., Schoots, I.G., Bokhorst, L.P., Bangma, C.H., Roobol, M.J.

Get full text

39 Wat is de klinische relevantie van unilaterale vs. bilaterale positieve prostaatbiopten tijdens active surveillance? by van den Bergh, R.C.N., Bokhorst, L.P., van der Poel, H.G.

Get full text